CFM
Catalyst Funds Management Portfolio holdings
AUM
$362M
1-Year Return
42.71%
This Quarter Return
+18.75%
1 Year Return
+42.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$362M
AUM Growth
-$20.4M
(-5.3%)
Cap. Flow
-$55M
Cap. Flow
% of AUM
-15.19%
Top 10 Holdings %
Top 10 Hldgs %
19.16%
Holding
737
New
289
Increased
45
Reduced
94
Closed
308
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
$10.3M |
| 2 |
Amphenol
APH
|
$7.72M |
| 3 |
Applovin
APP
|
$6.08M |
| 4 |
Insmed
INSM
|
$4.75M |
| 5 |
CRH
CRH
|
$3.87M |
Top Sells
| 1 |
Rio Tinto
RIO
|
$11.5M |
| 2 |
NVIDIA
NVDA
|
$8.98M |
| 3 |
Pfizer
PFE
|
$7.17M |
| 4 |
iShares Bitcoin Trust
IBIT
|
$7.02M |
| 5 |
GE Vernova
GEV
|
$5.77M |
Sector Composition
| 1 | Technology | 19.52% |
| 2 | Financials | 14.68% |
| 3 | Industrials | 12.22% |
| 4 | Materials | 11.75% |
| 5 | Healthcare | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QIPT
401
Quipt Home Medical
QIPT
$113M
| $31.3K | 0.01% |
+17,500
| New | +$31.3K |
|
402
Zentalis Pharmaceuticals
ZNTL
$126M
| $31.1K | 0.01% |
+26,800
| New | +$31.1K |
|
403
Orchestra BioMed
OBIO
$148M
| $30.6K | 0.01% |
+11,400
| New | +$30.6K |
|
404
Getty Images
GETY
$772M
| $30.1K | 0.01% |
+18,145
| New | +$30.1K |
|
405
1stdibs.com
DIBS
$100M
| $30K | 0.01% |
+10,900
| New | +$30K |
|
406
Neumora Therapeutics
NMRA
$272M
| $28.9K | 0.01% |
+39,400
| New | +$28.9K |
|
407
Sutro Biopharma
STRO
$89.9M
| $27.5K | 0.01% |
+38,500
| New | +$27.5K |
|
408
Virgin Galactic
SPCE
$185M
| $27.3K | 0.01% |
+10,000
| New | +$27.3K |
|
409
NN Inc
NNBR
$125M
| $27.1K | 0.01% |
+12,900
| New | +$27.1K |
|
410
Invivyd
IVVD
$239M
| $26.7K | 0.01% |
+37,300
| New | +$26.7K |
|
411
TScan Therapeutics
TCRX
$108M
| $26.1K | 0.01% |
+18,000
| New | +$26.1K |
|
412
Fractyl Health
GUTS
$65.4M
| $25.6K | 0.01% |
+15,800
| New | +$25.6K |
|
413
Pyxis Oncology
PYXS
$118M
| $25.5K | 0.01% |
+23,200
| New | +$25.5K |
|
414
LiveOne
LVO
$51.2M
| $25.4K | 0.01% |
+33,700
| New | +$25.4K |
|
415
Aemetis
AMTX
$151M
| $25.3K | 0.01% |
+10,200
| New | +$25.3K |
|
416
Vera Bradley
VRA
$60.6M
| $25K | 0.01% |
+11,300
| New | +$25K |
|
417
GrowGeneration
GRWG
$90.3M
| $24.6K | 0.01% |
+26,300
| New | +$24.6K |
|
418
Zura Bio
ZURA
$143M
| $24.5K | 0.01% |
+23,300
| New | +$24.5K |
|
419
Agilon Health
AGL
$497M
| $24.4K | 0.01% |
+10,600
| New | +$24.4K |
|
420
Biomea Fusion
BMEA
$114M
| $23K | 0.01% |
+12,800
| New | +$23K |
|
421
Acumen Pharmaceuticals
ABOS
$87.2M
| $22.9K | 0.01% |
+19,700
| New | +$22.9K |
|
422
SKYX Platforms
SKYX
$133M
| $21.8K | 0.01% |
20,830
-12,621
| -38% | -$13.2K |
|
423
Actinium Pharmaceuticals
ATNM
$49.3M
| $20.3K | 0.01% |
+14,500
| New | +$20.3K |
|
424
Purple Innovation
PRPL
$122M
| $19.5K | 0.01% |
+26,700
| New | +$19.5K |
|
425
Roadzen
RDZN
$74.3M
| $18.8K | 0.01% |
+19,200
| New | +$18.8K |
|